Literature DB >> 20202462

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

Andrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, C Babis Andreadis, John C Byrd, Myron S Czuczman, Luis Fayad, Andres Forero, Martha J Glenn, Jon P Gockerman, Leo I Gordon, Nancy Lee Harris, Richard T Hoppe, Steven M Horwitz, Mark S Kaminski, Youn H Kim, Ann S Lacasce, Tariq I Mughal, Auyporn Nademanee, Pierluigi Porcu, Oliver Press, Leonard Prosnitz, Nashitha Reddy, Mitchell R Smith, Lubomir Sokol, Lode Swinnen, Julie M Vose, William G Wierda, Joachim Yahalom, Furhan Yunus.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20202462     DOI： 10.6004/jnccn.2010.0021

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  98 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases.

Authors:  Robin T Zon; Michael N Neuss
Journal:  J Oncol Pract       Date:  2010-07       Impact factor: 3.840

Review 3.  Discordant bone marrow involvement in non-Hodgkin lymphoma.

Authors:  Jennifer Brudno; Tamar Tadmor; Stefania Pittaluga; Alina Nicolae; Aaron Polliack; Kieron Dunleavy
Journal:  Blood       Date:  2015-12-17       Impact factor: 22.113

Review 4.  [Current treatment strategies for follicular lymphoma].

Authors:  W Hiddemann; E Hoster; C Schmidt; M Dreyling; M Unterhalt
Journal:  Internist (Berl)       Date:  2016-03       Impact factor: 0.743

5.  HIV-associated primary effusion lymphoma presenting as a paracardial mass.

Authors:  Heather Katz; Cielo Rose; Nina Thakker Rivera; Natasha Bray
Journal:  BMJ Case Rep       Date:  2015-02-27

6.  Targeting the PI3K/AKT/mTOR pathway in non-Hodgkin's lymphoma: results, biology, and development strategies.

Authors:  Jonathan H Schatz
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

7.  A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalp.

Authors:  Budhi S Yadav; Anshuma Bansal; Suresh C Sharma; Pankaj Malhotra; Nilanjan Ghosh; Matthias Holdhoff; Andrei Shustov; Marc Chamberlain; Herbert Newton; Priya Kumethkar; Jeffrey N Raizer; Jon Glass; Gloria J Morris
Journal:  Semin Oncol       Date:  2013-06       Impact factor: 4.929

8.  Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.

Authors:  Andrew J Ritter; Jordan S Goldstein; Amy A Ayers; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2019-01-11

9.  Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to "Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone". Haematologica. 2012;97(6):937-942.

Authors:  Vít Procházka; Jana Gazdová; Tomás Papajík
Journal:  Haematologica       Date:  2012-11       Impact factor: 9.941

10.  Nelarabine in the treatment of refractory T-cell malignancies.

Authors:  Andrew M Roecker; Amy Stockert; David F Kisor
Journal:  Clin Med Insights Oncol       Date:  2010-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.